Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,611.70 | 38.30 | 0.45% |
CAC 40 | 7,910.49 | 31.93 | -0.40% |
DAX 40 | 24,122.40 | 86.29 | 0.36% |
Dow JONES (US) | 41,860.44 | 816.80 | -1.91% |
FTSE 100 | 8,786.46 | 5.34 | 0.06% |
HKSE | 23,827.78 | 146.30 | 0.62% |
NASDAQ | 18,872.64 | 270.07 | -1.41% |
Nikkei 225 | 37,298.98 | 230.51 | -0.61% |
NZX 50 Index | 12,685.47 | 17.63 | -0.14% |
S&P 500 | 5,844.61 | 95.85 | -1.61% |
S&P/ASX 200 | 8,386.80 | 43.50 | 0.52% |
SSE Composite Index | 3,387.57 | 7.10 | 0.21% |